Most viruses of clinical relevance encode antagonists that interfere with the type I interferon (IFN) pathway thus promoting the establishment of the infection and pathology. The mechanisms involved in initiating the antiviral immune response in the presence of antagonists of the type I IFN pathway have not been identified. These mechanisms may represent novel targets to minimize pathology and/or may explain different clinical outcomes to common viral pathogens. Our group established that special defective forms of viral genomes (DVGs), which were until recently considered an epiphenomenon of in vitro virus replication, are potent danger signals that trigger the host response, even in the presence of virus-encoded antagonists. Moreover, we demonstrated that natural accumulation of DVGs in the lung during infection with the mouse respiratory pathogen Sendai virus (SeV) or with mouse-adapted influenza A virus (IAV) correlated with the onset of the antiviral response, and that production of the primary antiviral cytokine IFN beta was limited to the DVG-positive lung cellular fraction. Importantly, analysis of respiratory secretions from children infected with the SeV-related human respiratory syncytial virus (RSV) demonstrated that detection of DVGs is also associated with enhanced expression of transcripts for type I IFNs in humans. Notably, DVGs have been identified in the serum of patients infected with a variety of viruses and our data are the first demonstration that DVGs generated during an acute infection promote the onset of the immune response in vivo. We thus hypothesize that DVGs are essential for the induction of the antiviral response in infections with viruses that block the type I IFN pathway and that their presence determines the clinical outcome of the infection. The goals of this renewal application are (i) to identify unique molecular mechanisms governing the strong immunostimulatory ability of DVGs, (ii) to determine how do DVGs initiate the immune response in vivo, and (iii) to evaluate the role of RSV DVGs in the virus pathogenesis in the human lung. Overall, these studies will advance our understanding of the mechanisms involved in the onset of the innate immune response to virus infection and may have a significant impact on the development of novel antiviral treatments and prognostic tools.

Public Health Relevance

Identification of host and virus factors promoting efficient clearance of the viral infection and diminishing pathology should accelerate the design of novel antiviral treatments and prognostic tools. This application is centered on the study of defective viral genomes as key determinants of the host immune response against respiratory viruses.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Virology - B Study Section (VIRB)
Program Officer
Leitner, Wolfgang W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Veterinary Medicine
United States
Zip Code
Fisher, Devin G; Coppock, Gaia M; López, Carolina B (2018) Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination. Vaccine 36:4039-4045
Manzoni, Tomaz B; López, Carolina B (2018) Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence. Future Virol 13:493-503
Kenney, Adam D; Dowdle, James A; Bozzacco, Leonia et al. (2017) Human Genetic Determinants of Viral Diseases. Annu Rev Genet 51:241-263
Muallem, Gaia; Wagage, Sagie; Sun, Yan et al. (2017) IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection. PLoS Pathog 13:e1006173
Sun, Yan; López, Carolina B (2017) The innate immune response to RSV: Advances in our understanding of critical viral and host factors. Vaccine 35:481-488
Xu, Jie; Sun, Yan; Li, Yize et al. (2017) Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun 8:799
Nogusa, Shoko; Thapa, Roshan J; Dillon, Christopher P et al. (2016) RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. Cell Host Microbe 20:13-24
Philip, Naomi H; DeLaney, Alexandra; Peterson, Lance W et al. (2016) Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death. PLoS Pathog 12:e1005910
Xue, Jia; Chambers, Benjamin S; Hensley, Scott E et al. (2016) Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations. Front Microbiol 7:326
Sun, Yan; López, Carolina B (2016) Respiratory Syncytial Virus Infection in Mice and Detection of Viral Genomes in the Lung Using RT-qPCR. Bio Protoc 6:

Showing the most recent 10 out of 25 publications